Colostrinin, and uses thereof

Abstract

The use of Colostrinin as a medicament, particularly in the treatment of chronic disorders of the central nervous system and the immune system.

1 - 30 . (canceled)  
     
     
         31 . A pharmaceutical composition comprising an oral dosage form containing a preselected amount of Colostrinin in combination with a physiologically acceptable carrier.  
     
     
         32 . The pharmaceutical composition according to  claim 31 , wherein the Colostrinin is non-ovine Colostrinin.  
     
     
         33 . (canceled)  
     
     
         34 . The pharmaceutical composition according to  claim 31 , in a form suitable for absorption through the mucosa of the oral/nasopharyngeal cavity and/or in a form suitable for absorption in the alimentary canal.  
     
     
         35 . The pharmaceutical composition according to  claim 31 , in the form of a tablet, lozenge, gel, patch or plaster.  
     
     
         36 . The pharmaceutical composition according to  claim 31 , comprising 25 to 1000 micrograms of Colostrinin.  
     
     
         37 . The pharmaceutical composition according to  claim 31 , comprising 50 to 100 micrograms of Colostrinin.  
     
     
         38 - 40 . (canceled)  
     
     
         41 . A dietary supplement comprising an oral dosage form containing Colostrinin, in isolated form, formulated in combination with a physiologically acceptable carrier.  
     
     
         42 - 55 . (canceled)  
     
     
         56 . The pharmaceutical composition according to  claim 31 , wherein said Colostrinin is provided in an isolated form.  
     
     
         57 . The dietary supplement according to  claim 41 , wherein the dietary supplement is provided in solid or liquid form.  
     
     
         58 . A pharmaceutical composition comprising an oral dosage form containing a preselected amount of a nonapeptide having the amino acid sequence Val-Glu-Ser-Tyr-Val-Pro-Leu-Phe-Pro (SEQ ID NO: 1) in combination with a physiologically acceptable carrier.  
     
     
         59 . The pharmaceutical composition according to  claim 58 , wherein the nonapeptide is derived from a non-ovine source.  
     
     
         60 . The pharmaceutical composition according to  claim 58 , in a form suitable for absorption through the mucosa of the oral/nasopharyngeal cavity and/or in a form suitable for absorption in the alimentary canal.  
     
     
         61 . The pharmaceutical composition according to  claim 58 , in the form of a tablet, lozenge, gel, patch or plaster.  
     
     
         62 . The pharmaceutical composition according to  claim 58 , comprising 25 to 1000 micrograms of the nonapeptide.  
     
     
         63 . The pharmaceutical composition according to  claim 58 , comprising 50 to 100 micrograms of the nonapeptide.  
     
     
         64 . A dietary supplement comprising an oral dosage form containing a nonapeptide having the amino acid sequence Val-Glu-Ser-Tyr-Val-Pro-Leu-Phe-Pro (SEQ ID NO: 1), in isolated form, formulated in combination with a physiologically acceptable carrier.